Page 72 - Read Online

Ulusal. Plast Aesthet Res 2018;5:7 I http://dx.doi.org/10.20517/2347-9264.2017.81 Page 7 of 8

However since there are concerns about delayed hypersensitivity and late complications, in order to accept
it as a universally safe method, further studies with longer follow-up periods are required.

DECLARATIONS
Authors’ contributions
Ulusal BG contributed solely to the paper.

Financial support and sponsorship
None.

Conflicts of interest
There are no conflicts of interest.

Patient consent
An informed consent was obtained from each patient.

Ethics approval
The procedures followed were in accordance with the ethical standards of the responsible committee on
human experimentation.

Copyright
© The Author(s) 2018.

REFERENCES
1. Kaur M, Garg RK, Singla S. Analysis of facial soft tissue changes with aging and their effects on facial morphology: a forensic
perspective. Egypt J Forensic Sci 2015;5:46-56.
2. Ascher B, Coleman S, Alster T, Bauer U, Burgess C, Butterwick K, Donofrio L, Engelhard P, Goldman MP, Katz P, Vleggaar D. Full
scope of effect of facial lipoatrophy: a framework of disease understanding. Dermatol Surg 2006;32:1058-69.
3. Friedman O. Changes associated with the aging face. Facial Plast Surg Clin North Am 2005;13:371-80.
4. Narins RS, Beer K. Liquid injectable silicone: a review of its history, immunology, technical considerations, complications, and
potential. Plast Reconstr Surg 2006;118:S77-84.
5. Webster RC, Fuleihan NS, Gaunt JM, Hamdan US, Gaunt IM, Smith RC. Injectable silicone for small augmentations: twenty-year
experience in humans. Am J Cosm Surg 1984;1:1-10.
6. Chasan PE. The history of injectable silicone fluids for soft-tissue augmentation. Plast Reconstr Surg 2007;120:2034-40, discussion
2041-3.
7. Clark DP, Hanke CW, Swanson NA. Dermal implants: safety of products injected for soft tissue augmentation. J Am Acad Dermatol
1989;21:992-8.
8. Mojsiewicz-Pieńkowska K, Jamrógiewicz M, Szymkowska K, Krenczkowska D. Direct human contact with siloxanes (silicones) -
safety or risk part 1. Characteristics of siloxanes (silicones). Front Pharmacol 2016;7:132.
9. Naim JO, Ippolito KM, Lanzafame RJ. The effect of molecular weight and gel preparation on humoral adjuvancy of silicone oils and
silicone gels. Immunol Invest 1995;24:537-47.
10. Alam M, Danahey DG. Permanent injectables for soft-tissue augmentation: avoiding misinformation and a reprise of the breast implant
debacle. Arch Facial Plast Surg 2005;7:370-3.
11. Jones DH, Carruthers A, Orentreich D, Brody HJ, Lai MY, Azen S, Van Dyke GS. Highly purified 1000-cSt silicone oil for treatment of
human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial. Dermatol Surg 2004;30:1279-86.
12. Benedetto AV, Lewis AT. Injecting 1000 centistoke liquid silicone with ease and precision. Dermatol Surg 2003;29:211-4.
13. Duffy DM. Silicone: a critical review. Adv Dermatol 1990;5:93-107, discussion 108-9.
14. Orentreich DS. Liquid injectable silicone techniques for soft tissue augmentation. Clin Plast Surg 2000;27:595-612.
15. Orentreich NO. Soft tissue augmentation with medical grade fluid silicone. In: Rubin LR, editor. Biomaterials in reconstructive surgery.
St Louis (MO): Mosby; 1983. p. 859-81.
16. Carniol PJ, Ganc D, Klinger A. Evaluating the aesthetic patient. In: Carniol PJ, Monheit GD, editors. Aesthetic Rejuvenation Challenges
and Solutions: A World Perspective Hardcover. Boca Raton, FL: CRC Press; 2009. p. 1-36.